Literature DB >> 3572301

Sialophorin, a surface sialoglycoprotein defective in the Wiskott-Aldrich syndrome, is involved in human T lymphocyte proliferation.

S J Mentzer, E Remold-O'Donnell, M A Crimmins, B E Bierer, F S Rosen, S J Burakoff.   

Abstract

The mAb L10 was used to determine the distribution and the function of sialophorin, the heavily glycosylated surface molecule that is deficient/defective in lymphocytes of patients with the X-linked immunodeficiency Wiskott-Aldrich syndrome. Dual-parameter FACS analysis indicated that sialophorin is expressed on CD4+ and CD8+ lymphocytes, on a subpopulation of peripheral blood B lymphocytes, on all thymocytes, and on a subpopulation of bone marrow cells. Functional studies demonstrated that L10 mAb stimulates the proliferation of peripheral blood T lymphocytes as measured by stimulation of [3H]thymidine incorporation. The time course and magnitude of increased [3H]thymidine incorporation by T lymphocytes in response to L10 mAb paralleled that induced by anti-CD3 mAb. Effective stimulation was dependent on the presence of monocytes and the Fc portion of L10 mAb. Stimulation of lymphocytes by L10, like stimulation by anti-CD3 mAb, involves increased expression of 4F2, HLA-DR, and IL-2-R. These observations suggest that sialophorin functions in T cell activation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3572301      PMCID: PMC2188304          DOI: 10.1084/jem.165.5.1383

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  22 in total

1.  Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: differentiation antigens of rat lymphocytes.

Authors:  A F Williams; G Galfrè; C Milstein
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

Review 2.  Monoclonal antibodies: purification, fragmentation and application to structural and functional studies of class I MHC antigens.

Authors:  P Parham; M J Androlewicz; F M Brodsky; N J Holmes; J P Ways
Journal:  J Immunol Methods       Date:  1982-09-17       Impact factor: 2.303

3.  A monoclonal antibody (MMA) that identifies a differentiation antigen on human myelomonocytic cells.

Authors:  S N Hanjan; J F Kearney; M D Cooper
Journal:  Clin Immunol Immunopathol       Date:  1982-05

4.  Identification of a glycophorin-like molecule at the cell surface of rat thymocytes.

Authors:  W R Brown; A N Barclay; C A Sunderland; A F Williams
Journal:  Nature       Date:  1981-02-05       Impact factor: 49.962

5.  Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol).

Authors:  M A Arnaout; R F Todd; N Dana; J Melamed; S F Schlossman; H R Colten
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

6.  Reconstitution of normal megakaryocytopoiesis and immunologic functions in Wiskott-Aldrich syndrome by marrow transplantation following myeloablation and immunosuppression with busulfan and cyclophosphamide.

Authors:  N Kapoor; D Kirkpatrick; R M Blaese; J Oleske; M H Hilgartner; R S Chaganti; R A Good; R J O'Reilly
Journal:  Blood       Date:  1981-04       Impact factor: 22.113

7.  Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes.

Authors:  B F Haynes; M E Hemler; D L Mann; G S Eisenbarth; J Shelhamer; H S Mostowski; C A Thomas; J L Strominger; A S Fauci
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

8.  Surface protein abnormalities in lymphocytes and platelets from patients with Wiskott-Aldrich syndrome.

Authors:  R Parkman; E Remold-O'Donnell; D M Kenney; S Perrine; F S Rosen
Journal:  Lancet       Date:  1981 Dec 19-26       Impact factor: 79.321

9.  Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation.

Authors:  R Parkman; J Rappeport; R Geha; J Belli; R Cassady; R Levey; D G Nathan; F S Rosen
Journal:  N Engl J Med       Date:  1978-04-27       Impact factor: 91.245

10.  Bone marrow transplantation in the Wiskott-Aldrich syndrome. Complete hematological and immunological reconstitution.

Authors:  H D Ochs; L G Lum; F L Johnson; G Schiffman; R J Wedgwood; R Storb
Journal:  Transplantation       Date:  1982-11       Impact factor: 4.939

View more
  36 in total

Review 1.  CD43, a molecule with multiple functions.

Authors:  Y Rosenstein; A Santana; G Pedraza-Alva
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  CD43 gene expression is mediated by a nuclear factor which binds pyrimidine-rich single-stranded DNA.

Authors:  O C Farokhzad; J M Teodoridis; H Park; M A Arnaout; C S Shelley
Journal:  Nucleic Acids Res       Date:  2000-06-01       Impact factor: 16.971

3.  Hodgkin's cells express a novel pattern of adhesion molecules.

Authors:  P A Ellis; D N Hart; B M Colls; J C Nimmo; J E MacDonald; H B Angus
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

Review 4.  Wiskott-Aldrich syndrome: a multidisciplinary disease.

Authors:  G R Standen
Journal:  J Clin Pathol       Date:  1991-12       Impact factor: 3.411

5.  Germ-line mosaicism simulates genetic heterogeneity in Wiskott-Aldrich syndrome.

Authors:  B Arveiler; G de Saint-Basile; A Fischer; C Griscelli; J L Mandel
Journal:  Am J Hum Genet       Date:  1990-05       Impact factor: 11.025

Review 6.  Molecular characterization of CD34+ human hematopoietic progenitor cells.

Authors:  W Knapp; H Strobl; C Scheinecker; C Bello-Fernandez; O Majdic
Journal:  Ann Hematol       Date:  1995-06       Impact factor: 3.673

7.  Induction of neutrophil homotypic adhesion via sialophorin (CD43), a surface sialoglycoprotein restricted to haemopoietic cells.

Authors:  A R Rosenkranz; O Majdic; J Stöckl; W Pickl; H Stockinger; W Knapp
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

Review 8.  Surface proteins and glycoproteins of human leucocytes.

Authors:  V Horejsí; V Bazil
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

9.  Amplification of T cell blastogenic responses in healthy individuals and patients with acquired immunodeficiency syndrome.

Authors:  P E Harris; K Strba-Cechova; P Rubinstein; D Mann; D W King; N Suciu-Foca
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

10.  CD43, the major sialoglycoprotein of human leukocytes, is proteolytically cleaved from the surface of stimulated lymphocytes and granulocytes.

Authors:  V Bazil; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.